Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1995

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

The role of oral contraceptives in the treatment of hyperandrogenic

disorders.

AUTHORS

Burkman RT Jr

SOURCE

AMERICAN JOURNAL OF MEDICINE. 1995 Jan 16;98(1A):130S-136S.

ABSTRACT

Hyperandrogenism effects clinical symptoms (e.g., excess body hair and acne) that concern women. Combined oral

contraceptives (OCs) can treat these bothersome manifestations as well as address the effects of unopposed

estrogen common to hyperandrogenism among otherwise healthy women. OCs may improve excess androgen

conditions by suppressing gonadotropins, especially luteinizing hormone; reducing circulating androgens, especially

free testosterone; increasing serum androgen binding to sex hormone binding globulin; suppressing, adrenal

androgen secretion; inhibiting 5 alpha-reductase; and inhibiting binding of androgen receptors. Other benefits of

OCs, particularly low-dose OCs, among hyperandrogenic women include contraception, favorable effect on lipid

metabolism, good menstrual cycle control, and reduced risk of ovarian and endometrial cancer, pelvic inflammatory

disease, dysmenorrhea, and iron deficiency anemia. Providers need to consider other androgen-related problems of

each individual patient before prescribing OCs, such as diabetes, lipid/lipoprotein abnormalities, and hypertension.

Women with anovulatory hyperandrogenic conditions (e.g., polycystic ovarian syndrome) are more likely to have a

varied response to OC use than hyperandrogenic women who ovulate. The more estrogen dependent OCs appear to

benefit women with anovulatory hyperandrogenic conditions, however. OCs reduce hair cover in 60-100% of women

with hirsutism. They significantly improve acne also. OC use may diminish the risk of developing anovulation-

related endometrial hyperplasia. Low-dose OCs with the newer progestins (e.g., norgestimate and desogestrel) either

have no effect on or benefit metabolism. (PubHealth.info Document ID: CONT2T 3092-06)

PubHealth.info NOTE: The author(s) of this article titled, "The role of oral contraceptives in the treatment of

hyperandrogenic disorders.", is(are) Burkman RT Jr. The source of this article is "AMERICAN JOURNAL OF

MEDICINE. 1995 Jan 16;98(1A):130S-136S.". This article was published in 1995 in English language(s).

(PubHealth.info® Document ID: CONT2T 3092-06. All rights reserved with PubHealth.info) PIN: 8092

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.